Frequently Asked Questions About ABRT.CN

What does Albert Labs International Corp. do?

Albert Labs International Corp. (ABRT.CN) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is ABRT.CN's market cap?

Albert Labs International Corp. (ABRT.CN) has a market capitalization of approximately $372,066, as of July 15, 2024, based on the most recent share price and shares outstanding.

Does ABRT.CN pay a dividend?

No — Albert Labs International Corp. (ABRT.CN) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

Is ABRT.CN profitable?

Albert Labs International Corp. (ABRT.CN) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

ABRT.CN (Albert Labs International Corp.) is no longer actively trading.

This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.

ABRT.CN

Albert Labs International Corp.

CNQ·Biotechnology · Healthcare

C$0.01C$0.00+0.00%

Market capC$372.07K·Market closed·Jul 15 1:38 PM UTC

Price Chart

C$0.01+C$0.00 (+0.00%)today

−87.50%CAGR −44.15%

Select date range

FromTo

Feb 1, 2023Feb 1, 2023 → Aug 28, 2026· 3.6 yrsAug 28, 2026

Key Metrics

ABRT.CN does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings Date—

Last Report Date—

Reported vs Estimate—

Earnings Surprise—

FinancialsFinancials Tab

RevenueC$0.00

Net Income−C$2.31M

Net Margin—

Operating Cash Flow−C$512.56K

Capital ExpendituresC$20.06K

Free Cash Flow−C$492.50K

Return on Equity—

Return on Invested Capital3.9%

Net DebtC$10.02K

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for ABRT.CN and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how ABRT.CN's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for ABRT.CN and 80,000+ other tickers.

About Albert Labs International Corp.

Albert Labs International Corp. is a pharmaceutical research and development company dedicated to addressing urgent and underserved patient needs, particularly in critical mental health. The firm specializes in creating psilocybin-assisted therapies aimed at improving conditions such as anxiety, depression, and the psychological distress linked to cancer. This enterprise operates out of Burnaby, Canada.

CEO: Navchand Jagpal
Sector: Healthcare
Industry: Biotechnology
Exchange: CNQ
Website: albertlabs.com

Peers

Peers Tab

BTI.V

Bioasis Technologies Inc.

Cap

C$397.1K

CURE.CN

Biocure Technology Inc.

Cap

C$408.0K

NIRV.CN

Nirvana Life Sciences Inc.

Cap

C$337.6K

Latest News

News Tab

No recent news available.

Frequently Asked Questions About ABRT.CN

What does Albert Labs International Corp. do?: Albert Labs International Corp. (ABRT.CN) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is ABRT.CN's market cap?: Albert Labs International Corp. (ABRT.CN) has a market capitalization of approximately $372,066, as of July 15, 2024, based on the most recent share price and shares outstanding.
Does ABRT.CN pay a dividend?: No — Albert Labs International Corp. (ABRT.CN) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.
Is ABRT.CN profitable?: Albert Labs International Corp. (ABRT.CN) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.